Xgeva, cancer
FDA Warning Letters issued to four makers of caffeinated alcoholic beverages
The U.S. Food and Drug Administration today warned four companies that the caffeine added to their malt alcoholic beverages is an “unsafe food additive” and said that further action, including seizure of their products, is possible under federal law. (DSK)
FDA approves new treatment option for late-stage breast cancer
Halaven, metastatic breast cancer
FDA launches initiative to develop innovative external defibrillators
Safety concerns on the devices that treat abnormal heart rhythms also to be addressed. The U.S. Food and Drug Administration today announced a program aimed at facilitating the development of safer, more effective external defibrillators used to treat abnormal heart rhythms through improved design and manufacturing practices.
FDA Urges Consumers to be ‘Smart’ about Antibiotic Use
This year, millions of antibiotics will be prescribed. Antibiotics can be used to treat bacterial infections; however, they are commonly over-prescribed. Patients sometimes ask their health care professional to prescribe antibiotic drugs for viral infections, like the common cold, despite the fact that they will not work and may lead to potentially harmful side effects. The misuse of antibiotics has contributed to one of the world’s most pressing public health problems today, antibiotic resistance.
FDA Approves Egrifta to Treat Lipodystrophy in HIV Patients
lipodystrophy
Pharmaceutical Company Lawyer Charged with Obstruction and Making False Statements
Pharmaceutical Company Lawyer Charged with Obstruction and Making False Statements
Recall of Tylenol Cold Liquid Products
In consultation with the U.S. Food and Drug Administration (FDA), McNeil Consumer Healthcare, Division of McNEIL-PPC, Inc., is recalling, from the wholesale and retail level, three TYLENOL® Cold Multi-Symptom liquid products in order to update the labeling for these products. The specific products involved, listed below, are sold in the United States.
Recall of Children’s BENADRYL® Allergy FASTMELT® Tablets and Junior Strength MOTRIN® Caplets
In consultation with the U.S. Food and Drug Administration (FDA), McNeil Consumer Healthcare, Division of McNEIL-PPC, Inc. has initiated a voluntary recall of all product lots of Children’s BENADRYL® Allergy FASTMELT® Tablets, in cherry and grape flavors, that were distributed in the United States, Belize, Barbados, Canada, Puerto Rico, St. Martin, and St. Thomas and all product lots of Junior Strength MOTRIN® Caplets, 24 count, that were distributed in the United States.
Recall of ROLAIDS® Extra Strength Softchews
In consultation with the U.S. Food and Drug Administration (FDA), McNeil Consumer Healthcare, Division of McNEIL-PPC, Inc. has initiated a voluntary recall of one product lot of ROLAIDS® Extra Strength Softchews, Cherry Flavor, 36 count package distributed in the United States.